Accessibility links
U.S. OKs New Colon-Cancer Drug The Food and Drug Administration approves a new drug for colon cancer -- the second-biggest cancer killer. Called Avastin, the new drug blocks tumors' blood supply. Earlier in February, the FDA approved Erbitux, which shrinks colon tumors by blocking a protein they need to grow. Each drug is the first of its kind. NPR's Richard Knox reports.
NPR logo

U.S. OKs New Colon-Cancer Drug

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/1718071/1718072" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
U.S. OKs New Colon-Cancer Drug

Science

U.S. OKs New Colon-Cancer Drug

Heard on Morning Edition

U.S. OKs New Colon-Cancer Drug

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/1718071/1718072" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Food and Drug Administration approves a new drug for colon cancer — the second-biggest cancer killer. Called Avastin, the new drug blocks tumors' blood supply. Earlier in February, the FDA approved Erbitux, which shrinks colon tumors by blocking a protein they need to grow. Each drug is the first of its kind. NPR's Richard Knox reports.